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Summary
Purpose: To analyze the validity and reliability of an epilepsy specific health related
quality of life (HRQL) instrument (QVCE-50), constructed for Brazilians. The QVCE-50
comprises the following domains: physical (9 items), psychological (18 items), social/
familial (7 items), and cognitive/educational (16 items). Items were scored on a four
point scale. Domains were equally weighted using percent scores. The questionnaire
ends with a quality of life scale scored 0—10 and a space for free observations.
Methods: A total of 77 children with epilepsy were consecutively seen in a neuro-
paediatric ambulatory unit. Parents or caregivers responded to the QVCE-50 and a
Portuguese version of ICIS (Impact of Childhood Illness Scale). QVCE-50 was analyzed
for internal consistency, reliability, content and concurrent validity. Clinical and
socio-demographic variables were also analyzed.
Results: Socio-demographic and clinical variables that differed in at least one domain
were age, sex, time since diagnosis, epilepsy family history, and antiepileptic drug
used. Internal consistency, analyzed by Cronbach’s alpha, showed good results for
total and domain scores: physical (0.68), psychological (0.86), socio-familiar (0.70)
and cognitive-educational (0.91). Total scores on the QVCE-50 and ICIS are inversely* Corresponding author at: Rua 16 de Marc¸o 102/203 Centro-Petro´polis, Rio de Janeiro, CEP 25620-040, Brazil. Tel.: +51 24 22377479;
fax: +51 24 22377479.
E-mail address: hebersmf@gmail.com (H.S. Maia Filho).
1 Professionals interested to receive a copy of QVCE-50 or to receive other psychometric data for deep analysis, please contact author
at (hebersmf@gmail.com).
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correlated (Pearson’s r = 0.74, p < 0.0001). The Intraclass Correlation Coefficients
for test—retest reliability were acceptable: physical (0.51), psychological (0.62),
socio-familiar (0.66), cognitive-educational (0.85) and total (0.77), p < 0.0001.
Conclusions: QVCE-50 has goodpsychometric properties. It is a useful tool for analyzing
HRQL in children with epilepsy for Portuguese speakers, especially Brazilians. Other
properties should be further tested, such as responsiveness to drug and surgical
treatment, capacity of distinguishing among seizure control categories and etiology
(with a larger sample) and impact of psychiatric and cognitive co-morbidities.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Epilepsy is one of the most prevalent chronic dis-
orders in childhood, affecting children’s physical
and cognitive health and psychosocial adjust-
ment.1,2 Since we have attained great advances in
epilepsy control by means of pharmacological and
surgical treatment, attention has moved to the
understanding of the impact of the disease on men-
tal health and quality of life.
HRQL is a multidimensional construct that deals
with a person’s perceptions about disease burden on
several dimensions of life (physical, psychosocial,
cognitive, and work).3 There are some important
HRQL instruments specific for children and adoles-
cents with epilepsy.4—8 Their development meth-
odologies are quite different, as are the ages and
epilepsy type spectrum covered, domains that are
measured, respondent (proxy versus patient) and
number of items.9 Most of them are for English
speakers.
It is important to develop and validate HRQL
instruments for people with epilepsy living in
developing countries where the majority of chil-
dren with epilepsy live. There are only one generic
HRQL instrument for children with epilepsy vali-
dated in Portuguese, developed originally in Eng-
lish.10 There are two other psychosocial
inventories of national origin.11,12 The QVCE-50
(Qualidade de Vida da Crianc¸a com Epilepsia/Qual-
ity of Life of Children with Epilepsy–—50 questions)
has been developed and partially validated in
Brazil.13 QVCE-50 development followed a sys-
tematic approach14 with items derived from pre-
vious scales, revisions based on theoretical
considerations, and the author’s clinical experi-
ence. Items were critically reviewed for complex-
ity, ambiguity and subjectivity, with some of them
being modified or discarded. Content and face
validity were taken into consideration. A pilot
questionnaire of 157 questions was given to 51
families, and then the number of items was
reduced after these qualitative and psychometric
properties were considered. The aim of the pre-
sent study is to analyze the QVCE-50’s validity andreliability with a larger sample of children and
adolescents with epilepsy.Method
Subjects
Seventy-seven children and adolescents attending
the neuropaediatric clinic at the Ambulatory Divi-
sion of Petro´polis School of Medicine, Rio de Janeiro,
Brazil, recruited over a two year period were
enrolled in the study. All were regularly seen by
the principal author, and their parents (or care-
givers) were asked to consent to the study.
The inclusion criteria were: age between 6 and
17 years; a minimum of 6 months post-diagnosis,
regular medical attendance, regular school atten-
dance and absence of major co-morbidities (signif-
icant cognitive impairment, autism or severemotor
and sensorial handicaps) that could affect quality of
life.
Epilepsy diagnosis (seizure type and etiology) was
made according to the International League Against
Epilepsy–—ILAE criteria.15
Instruments
Parents (or caregivers) were asked to complete two
self-administered HRQL questionnaires: the QVCE-
50 and the ICIS.
The QVCE-50 is a specific health quality of life
instrument comprising the following domains: phy-
sical (9 items), psychological (18 items), social/
familial (7 items), and cognitive/educational (16
items). Items were scored one to four. Domains were
equally weighted by means of percent scores. The
questionnaire ends with a quality of life visual
analog scale scored 0 to 10, and a space for free
observations. Its pilot application showed promising
psychometric properties and also face and content
validity.7
The ICIS (Impact of Childhood Illness Scale) is a
generic HRQL questionnaire originally developed
and validated in English16 in children with epilepsy
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Table 1 Socio-demographic characteristics of
patients and family
Characteristic n (%)
Patients
Sex
Male 43 55.8
Female 34 44.2
School gradea
Special education 3 3.9
Kindergarten 8 10.4
Primary 42 54.6
Middle school 22 28.5
High school 2 2.6
Parents and family or responding relative
Mother 65 84.4
Other relatives 12 15.6
Marital state
Married 47 61
Separated 29 37.7
Single mother 1 1.3
Income (in minimal income–—MI)b
<1 17 22.4
1—2 36 47.4
3 20 26.3
>3 3 3.9
School grade of mothera
Illiterate 3 4
Primary school 46 61.3
Middle School 7 9.3
High school 14 18.7
College 4 5.4
Missed data 1 1.3
Familiar history of epilepsy
Positive 37 48.1
Negative 40 51.9
a Major respondent relative/American correspondence.
b Minimal income (350 reais. approximately 160 dollars).and diabetes. It has already been used in a validated
Portuguese version with Brazilian children with neu-
rological and neuropsychiatric disorders, including
epilepsy.9 The questionnaire has 30 questions and is
divided in four sections: impact of illness and its
treatment (5 items), impact on the child’s develop-
ment and adjustment (10 items), impact on the
parents (5 items) and impact on the family (10
items). Items are scored one to three, also with
percent score weighting.
The QVCE-50 and the ICIS are inversely related,
with lower QVCE-50 and higher ICIS scores repre-
senting worse quality of life.
To assess retest reliability, new copies of both
questionnaires were sent by mail after 1 month. An
additional open-ended questionnaire asked for
changes in seizure control, prescribed drugs and
familiar stressful events in the period. The same
member of the family answered the second ques-
tionnaires.
Statistical analysis
We compared the QVCE-50 domain scores with
some clinical and social-demographic variables
that should have an impact on the quality of life
(uncontrolled seizures, polytherapy, symptomatic
etiology, longer epilepsy duration, and marital
state) and others (sex and seizure type). The
correlations of the domain scores with quantita-
tive variables (epilepsy duration) were done using
Spearman rank-order correlations. The comparison
of the domain scores with the categorical variables
was made by means of the Student’s t-test (sex,
seizure type, drug therapy, and marital state) or
one-way analysis of variance followed by Tukey’s
test to determine whether there were significant
differences between the categories (seizure con-
trol state, and etiology). Seizure control (none,
few, and many seizures) and etiology (idiopathic,
cryptogenic, and symptomatic) categories were
also compared to: sex, epilepsy family history,
drug therapy, seizure frequency, mental, and
motor handicap (x2 test), age (one-way analysis
of variance) and epilepsy duration (Kruskal—Wallis
ANOVA). To determine the internal consistency of
the instrument, we used Cronbach’s alpha. In
order to analyze the contribution of each item
to the internal consistency, we used alpha item
deletion analysis. Concurrent validity was ana-
lyzed with a Pearson correlation between the
QVCE-50 and the ICIS total scores. Test—retest
reliability of QVCE-50 domains was analyzed by
the Intraclass Correlation Coefficient (ICC). The
level of significance adopted was 5%. The analyses
were run on SAS1 System.17Results
Demographic and clinical characteristics
Demographic characteristics of children and the
responding parents are summarized in Table 1. The
mean age was 10.8 years (range: 6—17 years). Mainly
mothers (84.4%) completed the questionnaire.
Diagnostic and clinical characteristics are sum-
marized in Table 2. There were no differences
among seizure control and etiology categories
except for absence of cases with mental retardation
or minor motor handicap in the idiopathic children
as expected based on the exclusion criteria.
Only 33 families (42.8%) sent back the question-
naires, which were used for test—retest analysis.
Only 10 of these children (30.3%) had new seizures
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Table 2 Clinical characteristics of patients
n (%)
Seizure number (last year)
None 29 37.7
Few (1—9) 36 46.8
Many (>10) 12 15.6
Seizure type
Partial
Simple partial 4 5.2
SP with secondary generalization 8 10.4
Complex partial 11 14.3
CP with secondary generalization 5 6.5
Generalized
Tonic—colonic 28 36.4
Tonic 8 10.4
Atonic 5 6.5
Absence 3 3.9
Myolonic 1 1.3
Multiple 4 5.2
Etiology
Idiopathic 55 71.4
Symptomatic 9 11.7
Cryptogenetic 13 16.9
Drug treatment
Phenobarbital 11 14.3
Phenytoin 6 7.8
Carbamazepine 23 29.9
Valproic acid 23 29.9
Primidone 3 3.9
Benzodiazepine 2 2.6
Lamotrigine 1 1.3
Polytherapy 8 10.4
Comorbid mental retardation 7 9.1
Comorbid mild motor deficit 3 3.9
Time since first seizure: 6—133 months (median 52.4).at the 1-month interval (three of them had to
change antiepileptic drug dosage–—AED), but they
not change seizure control category. Three families
(9.1%) had a stressful event, but they did not cate-
gorize them as significant in the children’s lives.
Psychometric properties of QVCE-50
Some clinical and demographic variables were posi-
tively correlated with some QVCE-50’s domains
(Table 3). There were significant correlations of
sex (male) with the cognitive-educational domain
and total score, seizure frequency (uncontrolled
seizures) with the physical and socio-familiar
domains, antiepileptic drug dosage (polytherapy)
with the physical domain and marital state (single)
with the physical and socio-familiar domains and the
total score. There was no significant correlation
with etiology, seizure type, time since diagnosis
or familial history of epilepsy. Table 4 shows thealpha reliability coefficients of QVCE-50’s four
domains. Cronbach’s alpha is usually considered
acceptable when greater than 0.70,18 but figures
between 0.60 and 0.80 have also been regarded as
acceptable for some research purposes.19 Alpha
item deletion analysis did not show any inconsistent
items. QVCE-50 and ICIS have good inverse correla-
tion of their total scores (Pearson: r = 0.74,
p < 0.0001). Table 4 also shows QVCE-50 reliability
by test—retest analysis (ICC), with good results.Discussion
QVCE-50 shows good internal consistency, reliability
and concurrent validity.
Deciding to focus on the parent’s view is contro-
versial, since there can be differences in responses
between proxies and pediatric patients, especially
for subjective domains, like personal feelings and
familiar dynamics.20 We took into consideration that
the perception of health and disease matures with
age and is different across stages of life21,22 and that
the QVCE-50 was not primarily developed to attend
to these questions. Ronen et al.3 has constructed the
only HRQL epilepsy questionnaire suited for this age
differences until now.
The number of patients chosen was according to
literature about samples for questionnaire valida-
tion.14
The QVCE-50 demonstrated good homogeneity in
all domains, especially the psychological and cog-
nitive-educational ones. Criteria on validity was
shown for some domains. At the pilot testing, only
the physical domain attained some construct valid-
ity, specifically when comparing different levels of
seizure control.13 At this time, other domains were
also affected by some clinical and social variables
that we could infer are correlated with a poorer
quality of life, such as uncontrolled seizures and
polytherapy. We found a correlation between mar-
ital status and poor HRQL (physical and socio-famil-
iar domains). Epilepsy changes the familial
dynamics in many ways, including control and com-
petence sense of family members, parental roles
relative to child physical and social restrictions and
beliefs about social and educational compe-
tence.23—26 A single parent may have more difficulty
dealing with a child with epilepsy, also implying a
worse quality of life. Devinsky et al.27 identified
some risk factors for poor HRQL in adolescents with
epilepsy, including older age, female sex, uncon-
trolled seizures and antiepileptic drug effects. Our
sample had a larger age variance, with no correla-
tion of age and poorer HRQL and also a male pre-
ponderance in educational domain (a bias of
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Table 3 Correlation of the QVCE-50 scores and selected variables
Variables/domains Physical Psychological Socio-familiar Cognitive-educational
Mean
score
S.D. p-value Mean
score
S.D. p-value Mean
score
S.D. p-value Mean
score
S.D. p-value
Etiology
Idiopathic 75.8 14.4 0.47 74.9 13.4 0.50 85.3 13.2 0.35 76.5 16.4 0.25
Cryptogenetic 76.2 7.5 75.5 10.0 85.7 6.4 70.1 16.3
Symptomatic 70.9 10.6 70.4 11.9 79.7 14.1 69.1 17.6
Seizure type
Partial 72.6 15.2 0.26 73.3 12.8 0.73 80.2 14.5 0.07 73.6 16.3 0.75
Generalized 76.2 11.9 74.3 13.1 86.0 11.9 74.9 17.2
Seizure frequency
None 83.3 11.2 0.00 76.1 11.8 0.60 89.9 8.7 0.01 77.4 15.7 0.49
Few (1—9) 71.8 11.1 72.9 13.9 82.8 13.5 72.7 18.3
Many (>10) 64.4 12.1 73.6 12.1 75.6 13.7 72.9 14.2
Drug treatment
Monotherapy 76.2 13.1 0.02 74.2 12.7 0.88 85.2 12.6 0.08 75.0 16.6 0.43
Polytherapy 64.6 8.5 74.8 14.3 76.8 13.1 70.1 18.4
Sex
Male 74.2 12.9 0.56 72.5 13.8 0.18 83.1 13.2 0.31 69.5 16.6 0.01
Female 76.0 13.6 76.4 11.2 86.0 12.2 80.8 14.8
Marital state
Single 77.4 13.0 0.05 76.5 11.3 0.08 87.4 11.1 0.01 77.5 15.8 0.06
Married 71.3 12.9 71.4 14.0 79.2 14.0 70.2 17.4
Family history
Positive 76.1 12.0 0.47 74.5 11.9 0.83 84.3 12.5 0.94 72.8 15.9 0.37
Negative 74.0 14.2 73.9 13.7 84.5 13.2 76.1 17.4
Bold digits show the variables with significant differences.
Table 4 QVCE domain results
QVCE-50 domains Score S.D. Cronbach’s alpha ICC p-value
Physical 75.0 13.2 0.68 0.51 0.0009
Psychological 74.2 12.8 0.86 0.62 <0.0001
Socio-familiar 84.4 12.8 0.70 0.66 <0.0001
Cognitive-educational 74.5 16.7 0.91 0.85 <0.0001cognitive and behavioural comorbidities is a possi-
bility). In relation to the other variables with no
positive correlation with the instruments’ domains,
we could infer that etiology (symptoms) could have
some correlation. The physical domain remained
the most sensitive to these variable changes, prob-
ably because it contains clinical aspects of this
disease. Another question to be raised is the pre-
valence of few uncontrolled patients and the
absence of great co-morbidities. The ICIS, when
applied to a heterogeneous sample of children with
epilepsy (with or without great co-morbidities)
showed good discriminant validity, especially in
relation to epilepsy etiology. Since the QVCE-50
and the ICIS showed an inverse correlation (concur-
rent validity), we can infer that it would be the case
if QVCE-50 was applied to a large and heterogeneoussample. We have a 57% loss of the second question-
naires, but it seems not to compromise test—retest
analysis. The different places of questionnaire
application (ambulatory and home) does not seem
to affect or bias the answers since it was self-
administered at both times.Conclusion
QVCE-50 has good psychometric properties. It is a
useful tool for analyzing HRQL in children with
epilepsy for Portuguese speakers, especially Brazi-
lians. Other properties should be further tested,
such as responsiveness to drug and surgical treat-
ment, capacity of distinguishing among seizure con-
trol categories and etiology (with a larger sample)
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ities and their treatment.Acknowledgment
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